
🐳 The 3 stocks with the most noteworthy unusual option block trades! What are they betting on?
①$Karyopharm Therap(KPTI.US) — Bullish
Option volume reached 13,511 contracts, 11 times the daily average. The main force bought 6,700 times (13,400 contracts in total) on the April 17th expiry 10/17.50 bullish call spread. Since the current open interest is only 2,800 contracts, this can be confirmed as entirely new positions, clearly indicating a bullish direction. HC Wainwright maintains a Buy rating with a target price of $15. The market may be betting on new XPOVIO indication data or M&A news.
② $Revolution Medicines(RVMD.US) — Neutral to Bullish (Sell Put Spread)
RVMD's put option volume exceeded 10,335 contracts, 65 times the average daily put volume. The main force sold 5,000 contracts of the 90/70 put vertical spread, collecting a premium of $6.25 per contract, indicating institutions believe the stock price will not fall below $90. Previous acquisition talks (with Merck) broke down due to price disagreements, but analysts remain optimistic about its RAS-targeted pipeline and dense 2026 milestone schedule. The company expects to disclose key Phase III RASolute 302 data for daraxonrasib in pancreatic cancer in the first half of this year.
③ $Exxon Mobil(XOM.US) — Super Aggressively Bullish
A single $12 million bullish block trade appeared after-hours, executed at the Ask price, with a volume/open interest ratio as high as 4,562 times. The strike price even exceeded the market's implied volatility cap. The background is a Wall Street Journal report that US fighter jets and helicopters have begun operations to reopen the Strait of Hormuz, sharply increasing geopolitical oil price risks.
⚠️ Risk Warning: Unusual option activity only reflects market activity, does not represent insider information, and does not constitute any investment advice. Option trading carries extremely high risks; please evaluate carefully.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
